5 results
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
Macrophage Activation ... IL-1 and IL-6, leading ... nervous system (CNS) dysfunction ... rash) • Heart, lung ... Syndrome #Diagnosis #Management
Shock Classification
Shock Definition: State of cellular and tissue hypoxia due to: reduced oxygen delivery, increased oxygen
END-ORGAN DYSFUNCTION ... Hemorrhagic → leading ... Types #diagnosis #management ... warm #wet #dry #table
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
dissociation rate, leading ... agonist with a long ... mu-opioid-receptor activation ... the sublingual tablet ... Pharmacokinetics #Comparison #Table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... with valvular dysfunction ... or LV dysfunction ... unless prior heart/lung ... medical and surgical management
Langerhans Cell Histiocytosis (LCH)

Granulomatous Lesions comprising langerin-positive histiocytes and an inflammatory infiltrate can arise in virtually
various tissues, leading ... the bones, skin, lungs ... • Endocrine Dysfunction ... marrow: Organ dysfunction ... Histiocytosis #Diagnosis #Management